Literature DB >> 20024497

Proteolytic resistance conferred to fibrinogen by von Willebrand factor.

A Tanka-Salamon1, K Kolev, R Machovich, E Komorowicz.   

Abstract

The formation of platelet-rich thrombi under high shear rates requires both fibrinogen and von Willebrand factor (VWF) as molecular adhesives between platelets. We attempted to describe the role of VWF as a potential substrate and modulator of the fibrinolytic system using binding assays, as well as kinetic measurements on the cleavage of fibrin(ogen) and a synthetic plasmin substrate (Spectrozyme-PL). The similar dissociation constants for the binding of plasminogen, plasmin, and active site-blocked plasmin onto immobilised VWF suggest that the primary binding site in plasmin(ogen) is not the active site. The progressive loss of clottability and generation of degradation products during fibrinogen digestion with plasmin were delayed in the presence of VWF at physiological concentrations, while VWF cleavage was not detectable. Determination of kinetic parameters for fibrinogen degradation by plasmin, miniplasmin and microplasmin showed that VWF did not modify the Km, whereas kcat values decreased with increasing VWF concentrations following the kinetic model of non-competitive inhibition. Inhibitory constants calculated for VWF were in the range of its physiological plasma concentration (5.4 mg/ml, 5.7 mg/ml and 10.0 mg/ml for plasmin, miniplasmin and microplasmin, respectively) and their values suggested a modulating role of the kringle 5 domain in the interaction between VWF and (mini)plasmin. VWF had no effect on the amidolytic activity of plasmin on Spectrozyme-PL, or on fibrin dissolution by (mini)plasmin. Our data suggest that VWF, while a poor plasmin substrate relative to fibrinogen, protects fibrinogen against degradation by plasmin preserving its clottability in plasma and its adhesive role in platelet-rich thrombi.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20024497      PMCID: PMC2816671          DOI: 10.1160/TH09-07-0420

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  34 in total

Review 1.  Basic and clinical aspects of fibrinolysis and thrombolysis.

Authors:  D Collen; H R Lijnen
Journal:  Blood       Date:  1991-12-15       Impact factor: 22.113

2.  Flow rate-modulated dissolution of fibrin with clot-embedded and circulating proteases.

Authors:  E Komorowicz; K Kolev; I Léránt; R Machovich
Journal:  Circ Res       Date:  1998-06-01       Impact factor: 17.367

3.  Chemokine receptor-ligand interactions measured using time-resolved fluorescence.

Authors:  J Inglese; P Samama; S Patel; J Burbaum; I L Stroke; K C Appell
Journal:  Biochemistry       Date:  1998-02-24       Impact factor: 3.162

4.  Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions.

Authors:  S Goto; Y Ikeda; E Saldívar; Z M Ruggeri
Journal:  J Clin Invest       Date:  1998-01-15       Impact factor: 14.808

5.  Functional evaluation of the structural features of proteases and their substrate in fibrin surface degradation.

Authors:  K Kolev; K Tenekedjiev; E Komorowicz; R Machovich
Journal:  J Biol Chem       Date:  1997-05-23       Impact factor: 5.157

6.  Quantitative comparison of fibrin degradation with plasmin, miniplasmin, neurophil leukocyte elastase and cathepsin G.

Authors:  K Kolev; E Komorowicz; W G Owen; R Machovich
Journal:  Thromb Haemost       Date:  1996-01       Impact factor: 5.249

Review 7.  The elastase-mediated pathway of fibrinolysis.

Authors:  R Machovich; W G Owen
Journal:  Blood Coagul Fibrinolysis       Date:  1990 Mar-Apr       Impact factor: 1.276

8.  Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor.

Authors:  B Savage; E Saldívar; Z M Ruggeri
Journal:  Cell       Date:  1996-01-26       Impact factor: 41.582

9.  Proteolysis of von Willebrand factor after thrombolytic therapy in patients with acute myocardial infarction.

Authors:  A B Federici; S D Berkowitz; T S Zimmerman; P M Mannucci
Journal:  Blood       Date:  1992-01-01       Impact factor: 22.113

10.  Regulation of fibrinolytic activity of neutrophil leukocyte elastase, plasmin, and miniplasmin by plasma protease inhibitors.

Authors:  K Kolev; I Léránt; K Tenekejiev; R Machovich
Journal:  J Biol Chem       Date:  1994-06-24       Impact factor: 5.157

View more
  4 in total

1.  Extracellular Histones Inhibit Fibrinolysis through Noncovalent and Covalent Interactions with Fibrin.

Authors:  Matthew Locke; Colin Longstaff
Journal:  Thromb Haemost       Date:  2020-11-01       Impact factor: 5.249

2.  Shock-induced systemic hyperfibrinolysis is attenuated by plasma-first resuscitation.

Authors:  Hunter B Moore; Ernest E Moore; Alexander P Morton; Eduardo Gonzalez; Miguel Fragoso; Michael P Chapman; Monika Dzieciatkowska; Kirk C Hansen; Anirban Banerjee; Angela Sauaia; Christopher C Silliman
Journal:  J Trauma Acute Care Surg       Date:  2015-12       Impact factor: 3.313

3.  Modulation of the von Willebrand factor-dependent platelet adhesion through alternative proteolytic pathways.

Authors:  Nikolett Wohner; András Kovács; Raymund Machovich; Krasimir Kolev
Journal:  Thromb Res       Date:  2011-12-15       Impact factor: 3.944

4.  Screening of lncRNA-miRNA-mRNA Coexpression Regulatory Networks Involved in Acute Traumatic Coagulation Dysfunction Based on CTD, GeneCards, and PharmGKB Databases.

Authors:  Yong Luo; Yong Fu; Taifa Tan; Jun Hu; Fang Li; Zhanchen Liao; Jian Peng
Journal:  Oxid Med Cell Longev       Date:  2022-04-19       Impact factor: 7.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.